Bluejay Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Brelovitug (BJT-778) for the Treatment of Chronic Hepatitis Delta
Brelovitug has previously received Orphan and PRIME designation from the European Medicines Agency.
FDA proposes mandatory front-of-package nutrition labels to combat spike in chronic diseases
The U.S. Food and Drug Administration (FDA) is demanding increased, in-your-face food transparency when it comes to nutrition ...
Innovate Shares Gain After FDA Approves Kidney-Function Assessment Device
Shares of Innovate rose after the Food and Drug Administration approved the company's device to assess kidney function. The stock was 43% higher, at $7.30, midday Tuesday, the first day of trading ...
Innovate Corp. stock soars on FDA approval
Shares of Innovate Corp. (NYSE:VATE) surged 60% following the announcement that the U.S. Food and Drug Administration (FDA) ...
The National Law Review8h
FDA Issues New Recommendations on Use of AI for Medical Devices, Drugs, and Biologics
In its most recent effort to keep pace with advancing technology, the US Food and Drug Administration (FDA) recently issued ...
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces it has engaged ...